Living will — making a legally valid advance medical directive

An advance medical directive — commonly called a "living will" — is a written instrument by which an adult of sound mind specifies, while competent, the medical treatment he or she wishes to receive (or to refuse) at a future point when he or she is no longer competent to communicate. The instrument was first recognised in Indian law by the Supreme Court Constitution Bench in Common Cause (A Regd Society) v Union of India, (2018) 5 SCC 1, the same judgment that anchored the right to die with dignity in Article 21 of the Constitution of India. The detailed procedure laid down in 2018 was, in practice, so cumbersome that almost no advance directive was executed under it in the five years that followed. The Supreme Court on 24 January 2023, in Common Cause v Union of India, MA 1699/2019 in WP (Civil) 215/2005, substantially modified the procedure to make it operational. This guide sets out the modified procedure step by step — the format and execution requirements, the role of the two attesting witnesses and the Judicial Magistrate of First Class, custody and revocation, the primary and secondary medical-board procedures for withdrawal of life support, and the role of the Collector or District Officer — and cross-references the companion guide on the underlying right to refuse treatment.

The Supreme Court Constitution Bench in Common Cause (A Regd Society) v Union of India, (2018) 5 SCC 1 recognised, for the first time in Indian law, that a competent adult may execute a written directive specifying the medical treatment he or she wishes — or does not wish — to receive at a future point when he or she has lost the capacity to communicate. The 2018 judgment anchored the directive in the right to live with dignity under Article 21 of the Constitution, building on Aruna Ramchandra Shanbaug v Union of India, (2011) 4 SCC 454 (passive euthanasia for patients in permanent vegetative state) and Justice K S Puttaswamy v Union of India, (2017) 10 SCC 1 (bodily autonomy as a privacy interest). The original procedure was, however, so layered that almost no advance directive was executed under it. A five-judge bench order in Common Cause v Union of India, MA 1699/2019 in WP (Civil) 215/2005, dated 24 January 2023, rationalised the procedure. This article sets out the modified procedure end-to-end. The doctrinal foundation — the patient's right to refuse treatment under Article 21 and the tort of battery — is set out in the companion guide on refusing life-saving treatment.

The doctrinal foundation — Common Cause and the right to die with dignity

The Constitution Bench in Common Cause (2018) held that the right to live with dignity under Article 21 of the Constitution of India includes the right to die with dignity. The right comprises (a) the contemporaneous refusal of medical treatment by a competent adult patient, and (b) the prospective refusal of treatment through a valid advance directive, which is to be honoured when the patient has lost capacity. The court distinguished Gian Kaur v State of Punjab, (1996) 2 SCC 648 — which had held that Article 21 does not include the right to commit suicide — on the basis that refusal of treatment, and withdrawal of life support in a terminal or permanent-vegetative case, is a non-intervention in the natural process of dying and not an active suicide. Active euthanasia — the administration of a lethal substance — remains a criminal offence under Section 103 of the Bharatiya Nyaya Sanhita, 2023 [Section 302 of the Indian Penal Code, 1860]; the doctrinal line between lawful passive withdrawal and unlawful active hastening is preserved.

The directive thus operates as the patient's autonomy projected forward in time. When the patient is competent and conscious, the contemporaneous refusal is binding. When the patient has lost capacity but has, while competent, executed a directive, the directive is the binding expression of the patient's autonomy. Where the patient has lost capacity and has not executed a directive, the family-and-medical-board procedure laid down in Aruna Shanbaug (2011) — with the High Court's parens-patriae jurisdiction available — supplies the surrogate-decision-making route.

Who can execute a directive — capacity, age, voluntariness

Three threshold conditions govern who can validly execute an advance medical directive under the Common Cause framework.

Adulthood. The directive can be executed only by a person who has attained the age of majority — eighteen years and above. Minors do not have capacity to execute an advance directive; parental consent is the default route for treatment decisions for minors, with the High Court's parens-patriae jurisdiction available in disputed cases.

Soundness of mind. The executant must be of sound mind and capable of understanding (a) the nature of the directive, (b) the medical conditions it contemplates, and (c) the consequences of refusal of treatment. Mental-illness diagnoses do not, by themselves, disqualify a person — decision-making capacity is decision-specific. Where the patient has a diagnosed mental illness, the specialised advance-directive regime under Section 5 of the Mental Healthcare Act, 2017 may also be relevant; the two regimes coexist, with the Mental Healthcare Act regime governing mental-illness treatment and the Common Cause regime governing physical-illness treatment.

Voluntariness and informed nature. The directive must be executed voluntarily, free of coercion, undue influence, or inducement. It must be made with the executant having full information about the consequences of the directive — typically through prior consultation with a treating physician or family physician. The Common Cause framework treats voluntariness and informed nature as cumulative requirements; absence of either renders the directive vulnerable.

What the directive must contain

The Constitution Bench in Common Cause (2018), as restated in the modified 2023 procedure, requires the directive to address the following matters in clear and unambiguous language.

The circumstances of activation. The directive must specify the medical conditions in which it is to be activated — typically a terminal illness with no hope of recovery, a permanent vegetative state, or a similar condition where the patient has lost the capacity to consent. The drafting must be sufficiently specific to identify the contemplated condition, yet sufficiently general to cover variants of it.

The treatment to be refused or withdrawn. The directive must specify the treatment that is to be refused or withdrawn — for example, mechanical ventilation, artificial nutrition and hydration, cardiopulmonary resuscitation, dialysis, or specific chemotherapy. The directive can also affirmatively specify treatments the executant does wish to continue — pain relief, comfort care, palliative measures.

Acknowledgement of consequences. The directive must contain an acknowledgement that the executant understands the consequences of the directive — including that the refusal or withdrawal may hasten death.

Designation of nominees. The executant should designate one or two guardians or close relatives who will give or refuse consent to the implementation of the directive when the activating circumstances arise. The nominees' written consent to act as such should be obtained and recorded on the face of the directive.

Provision for revocation. The directive must record the executant's right to revoke it at any time, in writing, while the executant remains competent.

Execution — the modified January 2023 procedure

The execution requirements under the Constitution Bench's modified order of 24 January 2023 are these.

Two attesting witnesses. The directive must be signed by the executant in the presence of two attesting witnesses, who must themselves sign the directive in token of attestation. The witnesses must be adults of sound mind, with no direct financial or beneficial interest in the executant's estate. The witnesses' role is evidentiary — they testify to the executant's capacity, voluntariness, and informed nature at the time of execution.

Authentication by a Judicial Magistrate of First Class. The directive must be authenticated by a Judicial Magistrate of First Class (JMFC) within whose jurisdiction the executant ordinarily resides. The JMFC's role is to satisfy himself or herself that the executant is competent, that the directive has been executed voluntarily and with full understanding of the consequences, and to record that satisfaction on the face of the document. The original 2018 procedure required, additionally, that the JMFC preserve a copy and forward another copy to a designated registry; the 2023 modification streamlined this custody chain.

Custody. Under the modified 2023 procedure, the executant retains the original directive. A copy is preserved by the JMFC. A copy may also be lodged with a designated officer of the local administration — the Collector or District Officer or a designated officer below the Collector — so that the directive is retrievable when the activating circumstances arise. The executant should also inform the nominees and the family physician of the existence and location of the directive.

The Collector / District Officer's role. The original 2018 procedure assigned a custodial role to the jurisdictional Collector. The 2023 modification retained the Collector / District Officer in the role of a designated officer who may be approached for verification when the activating circumstances arise. The precise delegation of this role within the State administration varies by State.

The execution procedure step by step

The practical execution of a valid living will under the modified 2023 procedure proceeds in five steps.

Step 1 — Consultation and drafting. The prospective executant consults the family physician (and, where relevant, a specialist treating physician for the condition in contemplation) to understand the medical conditions that may arise and the treatments that may be at issue. The directive is drafted to reflect the executant's informed choices. Templates are circulating in clinical and palliative-care literature; the Indian Society of Critical Care Medicine has published model templates that map to the Constitution Bench's requirements.

Step 2 — Identification of witnesses and nominees. Two independent adult witnesses are identified — typically not the immediate beneficiaries under the executant's will, to insulate the directive from any future challenge on the ground of beneficial interest. One or two nominees — typically the spouse, an adult child, or a sibling — are identified to act as decision-makers when the activating circumstances arise. The nominees' written consent to so act is obtained and annexed to the directive.

Step 3 — Execution before the JMFC. The executant attends before the jurisdictional JMFC with the two witnesses. The JMFC examines the executant to be satisfied of capacity, voluntariness and informed nature; records that satisfaction on the face of the directive; and authenticates the directive. The JMFC retains a copy.

Step 4 — Lodging and intimation. A copy of the authenticated directive is lodged with the designated officer (Collector or District Officer or designated subordinate officer). The executant retains the original. Copies are provided to the nominees, the family physician, and (where the executant is already a patient of a hospital) the treating hospital's medical-records department.

Step 5 — Periodic review. Best practice — though not mandated by the Constitution Bench — is to review and reaffirm the directive periodically (typically every five years) and on any material change in the executant's medical condition or family circumstances. Reaffirmation is recorded as an endorsement on the original or as a fresh directive executed in supersession.

Revocation

The executant may revoke the directive at any time while he or she remains competent. Revocation is to be effected in writing, signed by the executant. The revoked directive should be marked as such, and intimation of the revocation should be given to the JMFC who authenticated the original, to the designated officer who holds the lodged copy, to the nominees, and to the family physician. Oral revocation by a competent patient — for example, a patient who, on being admitted to hospital, expressly contradicts the standing directive — is also effective; the contemporaneous expression of a competent patient's autonomy overrides the prospective directive.

Activation — the primary and secondary medical-board procedures

The activation procedure — the steps by which a directive is acted on when the activating circumstances arise — is the most heavily regulated part of the framework. The Constitution Bench laid down a two-tier medical-board procedure designed to prevent abuse of the directive and to ensure that the activating condition is genuinely present.

The primary medical board. When the activating circumstances arise — typically the patient has been admitted to a hospital with a terminal illness with no hope of recovery, or has fallen into a permanent vegetative state, or is otherwise in a condition contemplated by the directive — the hospital constitutes a primary medical board. The primary medical board consists of the treating physician and at least two other expert physicians from the hospital, with at least twenty years of relevant experience. The primary medical board examines the patient, reviews the directive, and decides whether the activating condition is present and whether withdrawal or withholding of the specified treatment is medically appropriate.

The secondary medical board. If the primary medical board concludes that the directive should be activated, a secondary medical board is constituted, comprising the Chief Medical Officer of the district (or a nominee) and three expert physicians, with at least twenty years of relevant experience, who are not part of the primary medical board. The secondary medical board independently examines the patient and reviews the directive, and either confirms or rejects the primary medical board's conclusion.

The 2023 simplification of timelines. The modified 2023 procedure tightened the timelines for the primary and secondary medical-board procedures. The boards are required to act expeditiously — typically within forty-eight hours of constitution — to avoid prolonging the patient's suffering through procedural delay.

The Judicial Magistrate's role at activation. Under the modified 2023 procedure, the role of the JMFC at the activation stage was rationalised. The original 2018 framework required the JMFC to authorise the withdrawal; the 2023 modification clarified that, once both medical boards have concurred and the nominees have consented, the withdrawal can proceed without a fresh JMFC authorisation, with the activation documented for record. Where any party disputes the activation, recourse to the jurisdictional High Court under Article 226 of the Constitution remains available.

The Aruna Shanbaug residual procedure. Where the patient has not executed a directive and falls into a condition where withdrawal of life support is in contemplation, the Aruna Shanbaug (2011) procedure continues to govern — close family members in consultation with the treating doctors, supported by the family-and-medical-board route, with the High Court's parens-patriae jurisdiction available. The Constitution Bench in Common Cause restated this residual procedure for patients without an advance directive.

Common drafting and execution pitfalls

Five drafting and execution pitfalls reduce the practical usefulness of an otherwise validly executed advance directive.

Vague activation circumstances. Directives drafted in general terms ("if I am terminally ill") leave the medical board with too much discretion and invite disputes with family members at the activation stage. The activating circumstances should be specified with reasonable medical precision — for example, "a terminal illness with a prognosis of less than six months and where the treating physicians have advised that further curative treatment is futile" — though excessive specificity risks excluding genuine activating conditions.

Conflating refusal of all treatment with refusal of life-prolonging treatment. A directive that purports to refuse all medical treatment is rarely the executant's actual intent. The standard drafting refuses life-prolonging or futile treatment while affirmatively retaining pain relief, comfort care and palliative measures. The distinction should be drawn clearly on the face of the directive.

Choosing beneficial-interest witnesses or nominees. Witnesses who stand to inherit under the executant's will, and nominees with a financial stake in the executant's death, expose the directive to challenge on the ground of undue influence. Independent witnesses and nominees who do not have a direct financial stake are preferred.

Failing to inform the treating hospital and family physician. A directive that exists but is not known to the treating clinical team at the moment of activation is, in practice, ineffective. The custody chain should ensure that the family physician, the nominees, and (where the executant has a continuing relationship with a hospital) the hospital records department all have copies.

Failing to reaffirm after a material change. A directive executed at age forty-five, never reaffirmed, and now sought to be activated at age seventy-five, may be challenged on the ground that the executant's circumstances and views have materially changed. Periodic reaffirmation — typically every five years and on any material change in medical or family circumstances — strengthens the directive's authority.

The pending legislation — Law Commission Report 241 and the Terminally Ill Patients Bill

The Law Commission of India in its Report No 241 of August 2012 — Passive Euthanasia: A Relook — drafted a comprehensive legislative framework on the right to die with dignity. The draft Medical Treatment of Terminally-Ill Patients (Protection of Patients and Medical Practitioners) Bill, annexed to the Report, was intended to codify (a) the right of a competent patient to refuse treatment, (b) the procedure for withdrawal of life support from incompetent patients, (c) protection from criminal and civil liability for physicians who comply with a valid directive, and (d) a statutory framework for advance medical directives.

The Bill was not enacted. The Government of India's response to the Law Commission's draft has been cautious, and the Constitution Bench in Common Cause (2018) noted, in its judgment, that the matter was, in the absence of legislation, governed by the court-laid procedure. The 2018 judgment and the 2023 modification together fill the legislative gap — but the underlying procedure remains a judicial creation, not a statutory regime. A statutory codification, when it comes, would resolve several second-order questions that the court-laid procedure necessarily leaves open — in particular, the precise composition of the medical boards, the State-level designation of the Collector / District Officer's role, and the criminal-law protection for physicians acting in good-faith reliance on a valid directive (currently anchored only in Sections 26 and 27 of the Bharatiya Nyaya Sanhita, 2023 [Sections 88, 89 and 92 of the Indian Penal Code, 1860] and in the constitutional protection in Common Cause itself).

Cross-references and interaction with other regimes

Three other statutory regimes interact with the Common Cause advance-directive framework and should be considered together with it.

The Mental Healthcare Act, 2017 advance-directive regime. Section 5 of the Mental Healthcare Act, 2017 recognises an advance directive for the treatment of mental illness. The Mental Healthcare Act regime is independent of, and parallel to, the Common Cause regime. A person may execute both — one for mental-illness treatment and one for end-of-life treatment for physical illness — and the two operate in their respective domains.

The Transplantation of Human Organs and Tissues Act, 1994. Where the executant wishes to combine the advance directive with a pledge to donate organs at the point of death, the requirements of the Transplantation of Human Organs and Tissues Act, 1994 — in particular Sections 3 and 9 — should be complied with in addition to the Common Cause framework.

The Indian Medical Council (Professional Conduct, Etiquette and Ethics) Regulations, 2002. The Regulations govern the professional conduct of registered medical practitioners and contain provisions on informed consent, withdrawal of treatment, and the doctor-patient relationship. Physicians acting on a valid advance directive should ensure compliance with the Regulations alongside the Common Cause framework; non-compliance can lead to disciplinary action by the National Medical Commission or the State Medical Council independently of any civil or criminal liability.

The doctrinal map — what the modified procedure achieves

The Supreme Court's 2023 modification of the Common Cause procedure achieves three things. It rationalises the execution chain — two attesting witnesses, JMFC authentication, retention by the executant and lodging with the designated officer — into a process that an ordinary citizen can complete in a single day. It tightens the activation timelines through the primary and secondary medical-board procedures, reducing the risk that an otherwise valid directive becomes operationally useless through delay. And it clarifies the relationship between the directive, the nominees, the medical boards, and the residual judicial supervision under Article 226 of the Constitution.

The framework remains a judicial creation. Until the Terminally Ill Patients (Protection of Patients and Medical Practitioners) Bill or a successor legislation is enacted, the Common Cause procedure as modified in 2023 is the operative law. For the executant, the practical lesson is that the directive must be drafted with care, executed with proper independent witnesses, authenticated by the JMFC, lodged appropriately, and made known to the family physician and the treating hospital. For the treating physician, the practical lesson is that a directive that satisfies the Common Cause requirements is binding — and that withdrawing or withholding treatment in compliance with such a directive, after the medical-board procedure has been completed, attracts the constitutional protection of Article 21 and the statutory protection of Sections 26 and 27 of the Bharatiya Nyaya Sanhita, 2023 [Sections 88, 89 and 92 of the Indian Penal Code, 1860]. The doctrinal foundation of the right that the directive operationalises — the patient's right to refuse treatment under Article 21 and the law of battery — is set out in the companion guide on refusing life-saving treatment.